We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Regs Plunged in 2017 But Other Developments Built on Obama-Era Trends
FDA Regs Plunged in 2017 But Other Developments Built on Obama-Era Trends
Although 2017 saw significantly fewer new FDA regulations, other regulatory and enforcement activities at the agency built on existing long-term trends, according to a new report from PriceWaterhouseCoopers (PwC).